🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A great presentation by Melanie Gunawardene APHRS2024 on managing post-PVI AT in the era of PFA. Advantages and limitations of different technologies and the remaining gaps.

A tour-de-force lecture on endo-epi VT by the incredibly talented Usha Tedrow. Coincidentally, we both enjoyed Mahler’s 4th Symphony last night at the Sydney Opera House. APHRS2024

🙏 and a thank you to Prash Sanders for inviting us all too beautiful Sydney! APHRS2024 #EPeeps

🙏🏻🙏🏻🙏🏻

Join us tomorrow to talk about our passion: EGMs! Looking forward to it! #AblateVT #EPeeps Theo Xenos Elad Anter Raphael Martins Register here! jnjinstitute.com/en-emea/events… Hospital Clínic barnaclínic+

Congrats Henry! However, a word of caution: Ablation Index has limited value for guiding ablation in the ventricle. The formula was not designed for it and very different lesion sizes are obtained with similar AI values. sciencedirect.com/science/articl…

Thank you Elad Anter for this incredible paper outlining the limitations of Ablation Index for the ventricle. A MUST read for all EP fellows! I am amazed when people are surprised by this. Nabeel Saghir Vy Jocson UC Cardiology Srinivas Rajsheker Paari Dominic @vijaywantbrar

It has been a privilege to share these days with Maxim Didenko, MD PhD @FredSacher_EP Elad Anter Thomas Deneke Marta de Riva and the course directors Andrea Sarkozy and Petr Peichl . A lot of lessons learned, thanks EHRAPresident for having me on board

Broken clocks are correct twice daily. I predicted it. medscape.com/viewarticle/ma… While trials are good, OPTION should not lead to more LAAC. Safety not superior (wrong primary). Efficacy noninferiority impossible to assess with low stroke rates. Working on a column now #AHA24

Dr.Louise Reilly, PhD, et al outline a new paradigm for identifying functional and molecular targets for #arrhythmia suppression in patients with idiopathic ventricular fibrillation. jacc.org/doi/10.1016/j.… #JACCCEP #EPeeps

I don’t want to connect my coffee machine to the wifi network. I don’t want to share the file with OneDrive. I don’t want to download an app to check my car’s fluid levels. I don’t want to scan a QR code to view the restaurant menu. I don’t want to let Google know my location

Feasibility and mid-term effectiveness of focal pulsed field ablation for ventricular arrhythmias @mruwald @copgag heartrhythmjournal.com/article/S1547-…

On October 7, 2023, terrorists in Gaza abducted a mother, her child, her infant son, and an 83 year old man and murdered them. More than 500 days later, Hamas returned them to Israel in coffins. We extend our deepest sympathies for the victims' families who have suffered the

A great study!

I agree—low/zero Fluoro is important for reducing back pain and radiation risks. But its emphasis is industry-driven, much like first-use product photos (who cares unless you invented it?). The real issue? Limited true advancements in solving core EP problems.

Beautiful case, Dr Vishal Luther! The real question I always have when considering anterior line is whether I’m treating a localized reentry that truly requires it, or if it’s for mitral flutter. In the latter case, a lateral line is more impactful and helps avoid bi-atrial flutters.

A new 3F hollow catheter to treat small vessel-related arrhythmias and has been proven to be efficacious and safe #AHAJournals #Epeeps doi.org/10.1161/CIRCEP…

So, debate continues here, now featuring Elad Anter and Atul Verma 🤼‍♂️ Substrate modification after PVI, is PFA the answer?? #EHRA_ESC 🇦🇹

Fantastic first session after lunch in #EHRA_ESC ablation innovation summit! With presentations from Pier Lambiase Elad Anter Ivo Roca, FEHRA, FESC & NataliaTrayanova With Marta de Riva and W. Stevenson as panelists 🙌🏼🇦🇹

Very interesting Jason!